You searched for "MIGS"
Team Arunodaya is happy to announce their August rewards!
Team Arunodaya is happy to announce that in the month of August, 2024, their doctors received the following prestigious awards.Sight Sciences OMNI® Masterclass, Colchester
23 January 2023
|
Awards, Conferences & Anniversaries
Saturday 14th January saw Sight Sciences hold their third UK Masterclass for the OMNI Surgical System.
iGLEAMS: The 2nd International Glaucoma Microsurgery Symposium East Anglia 2023
12 May 2023
-13 May 2023
Featuring 3D NGENUITY Gonio-Surgery with Lukan Mishev Friday 12 May. ICENI Centre Practical Skills Dry Labs on MiGS Course Director: Mr Chrysostomos Dimitriou MB ChB (Hons) FRCOphthFEBOphthFEBOS (Glau) PGCertMedEd(Healthcare) RCOphthCollege Tutor East Anglia Simulation Lead –Founder of iGLEAMS Saturday 13...
3rd iGLEAMS – East of England Glaucoma Microsurgery Conference
30 September 2024
-1 October 2024
Day 1 – Monday 30 September Firstsite, Colchester City Centre Key Note Speakers discussing the latest Glaucoma skills and techniques – Approved by the RCOphth for 6 CPD Points Day 2 – Tuesday 1 October ICENI Centre, Colchester Hospital Workshop...
Comparison of bleb grading and IOPs
1 October 2018
| Chrysostomos D Dimitriou
|
EYE - Glaucoma
The purpose of this study was to compare a novel anterior segment optical coherence tomography (AS-OCT) bleb grading system with a clinical bleb grading system (Moorfields) and both with intraocular pressure (IOP) levels following trabeculectomy surgery. The authors developed a...
Report: UKEGS 2024
29 October 2024
|
UKEGS, 2024, conferences, meetings, events, industry, glaucoma, Glaucoma UK, Nishani Amerasinghe, Andrew Tatham
It was an incredible experience heading down to UKEGS 2024 earlier this month in Southampton. The entire Glaucoma UK team, along with the UKEGS overseeing panel Nishani Amerasinghe, Andrew Tatham, Professir Anthony King and Professor Gus Gazzard, took great care...
Results after 1.4mm biaxial cataract surgery and implantation of a new aspheric intraocular lens
The aim of this study was to analyse the clinical outcome and higher-order aberrations (HOAs) after 1.4mm biaxial micro incision cataract surgery (B-MICS) and implantation of a new aspheric intraocular lens (IOL). A total of 157 eyes of 106 patients...Evolving towards an interventional glaucoma mindset
2 February 2024
| Gus Gazzard (Prof), Jan Beiting
|
EYE - Glaucoma
Traditionally, a newly diagnosed glaucoma patient would be treated first with medical therapy. As the disease progressed or the initial intervention failed to adequately control intraocular pressure (IOP), clinicians would add more drops, selective laser trabeculoplasty (SLT), repeated SLT and...
One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperative management
1 August 2018
| Sofia Rokerya
|
EYE - Glaucoma
The authors report a retrospective, non-randomised interventional case series of 39 patients who underwent a standalone XEN45 implantation. All 39 patients (female: male=1.2: 1) completed 12-month follow-up. Mean age was 70.1 years (range 32–92). Primary outcome measures were the intraocular...
Morning glory syndrome associated with PHPV
1 February 2014
| Jonathan Chan
|
EYE - Glaucoma
This is a retrospective review of the medical records of 85 eyes / 74 patients diagnosed as morning glory syndrome (MGS) in the clinic between November 2009 and November 2012. Twenty two eyes of 19 patients diagnosed as having MGS...
The National Student Ophthalmology Conference 2024
24 March 2024
This will be our third annual conference, hosted virtually with the aim to inform and inspire current medical students with interests in ophthalmology. It is a collaborative effort of student representatives from medical schools across the country. - 8 guest...
MicroRNA inhibits corneal neovascularisation
1 August 2018
| Graham Wallace
|
EYE - Cornea, EYE - General
|
Biomechanical stress, Corneal epithelium, MicroRNA-204, Neovascularization, VEGF, VEGFR2
MicroRNAs (miR) are small non-coding RNA that target mRNA for destruction. MiR target about 30% of the protein coding genes and fine tune their expression. MiR have been shown to be involved in several cellular processes including cell cycle, tissue...
